Tuesday, November 3, 2026
Two filings from small caps that hit EDGAR on November 2, 2026 and November 3, 2026, each with one factual line and a link to the source. Summaries of public SEC filings, not investment advice. Always read the filing.
Karyopharm Therapeutics filed for prepackaged Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas on November 2, 2026. The filing describes debtor-in-possession financing of up to $110 million.
Read the filing on sec.gov →Ribbon Acquisition says it received a Nasdaq notice on October 30, 2026 that it does not meet the market value of listed securities requirement; it has period of 180 calendar days, or until April 28, 2027, to regain compliance.
Read the filing on sec.gov →Today's full issue flagged 20 filings: auditor changes, restatements, delisting notices, bankruptcies and going-concern language, each linked to EDGAR. It's free, one email each weekday.
Unsubscribe anytime in one click. Not investment advice. See a sample issue →